Search results

Membership details, terms of reference, future meeting dates and past meeting minutes for our interventional procedures advisory committee.

Evidence-based recommendations on setmelanotide (Imcivree) for treating obesity caused by LEPR or POMC deficiency in people 6 years and over.

Result type

Highly specialised technologies guidance

Published

6 July 2022

Evidence-based recommendations on tocilizumab (RoActemra), for treating systemic juvenile idiopathic arthritis in people aged 2 and over.

Result type

Technology appraisal guidance

Published

14 December 2011

This guidance has been updated and replaced by NICE guideline CG181.

Result type

Clinical guideline

Published

28 May 2008

Evidence-based recommendations on tofacitinib (Xeljanz) for treating active ankylosing spondylitis.

Result type

Technology appraisal guidance

Published

18 October 2023

Evidence-based recommendations on endovascular atrial septostomy. This involves inflating a balloon passed into the heart with a catheter to try to make the hole bigger so that it does not close up completely.

Result type

Interventional procedures guidance

Published

25 August 2004

This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.

Result type

NICE guideline

Published

7 April 2021

Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in babies, children, young people and adults.

Result type

Highly specialised technologies guidance

Published

1 March 2023

Evidence-based recommendations on balloon dilatation of systemic to pulmonary arterial shunts in children. This involves inflating a balloon inserted into the area so blood can flow through more easily.

Result type

Interventional procedures guidance

Published

28 July 2004

Evidence-based recommendations on ponatinib (Iclusig) for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia in adults.

Result type

Technology appraisal guidance

Published

28 June 2017

This guideline covers how community pharmacies can help maintain and improve people’s physical and mental health and wellbeing, including people with a long-term condition. It aims to encourage more people to use community pharmacies by integrating them within existing health and care pathways and ensuring they offer standard services and a consistent approach. It requires a collaborative approach from individual pharmacies and their representatives, local authorities and other commissioners.

Result type

NICE guideline

Published

2 August 2018

Evidence-based recommendations on lebrikizumab (Ebglyss) for treating moderate to severe atopic dermatitis in people 12 years and over.

Result type

Technology appraisal guidance

Published

10 July 2024

NICE has developed a medtech innovation briefing (MIB) on the Spiral Flow peripheral vascular graft for treating peripheral arterial disease

Result type

Medtech innovation briefing

Published

21 July 2015

Evidence-based recommendations on enzalutamide (Xtandi) for treating hormone-sensitive metastatic prostate cancer in adults.

Result type

Technology appraisal guidance

Published

7 July 2021

This quality standard covers preventing dementia, and assessment, management and health and social care support for people with dementia. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Published

28 June 2019